Who has invested in Soley Therapeutics?

Surveyor Capital are named among the investors backing Soley Therapeutics.

Soley Therapeutics Funding: $220M Raised, Series C (2026)

Soley Therapeutics funding overview

Soley Therapeutics is based in San Francisco, California. Soley Therapeutics has raised $220M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2026. The round record for Soley Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Surveyor Capital.

Soley Therapeutics at a glance

Total raised: $220M
Latest round: Series C
Latest round date: January 2026
Headquarters: San Francisco, California
Notable investors: Surveyor Capital

Frequently asked about Soley Therapeutics funding

How much has Soley Therapeutics raised?: Soley Therapeutics has raised $220M in total disclosed funding across the rounds on record.
Who has invested in Soley Therapeutics?: Surveyor Capital are named among the investors backing Soley Therapeutics.
What was the latest Soley Therapeutics funding round?: The most recent disclosed round is a Series C, announced in January 2026.
Where is Soley Therapeutics based?: Soley Therapeutics is based in San Francisco, California.
When did Soley Therapeutics last raise?: The last disclosed Soley Therapeutics round closed in January 2026 at Series C.

We update the Soley Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Francisco and their backers are listed below.

Soley Therapeutics Funding: $220M Raised, Series C (2026)

Soley Therapeutics funding overview

Soley Therapeutics at a glance

Frequently asked about Soley Therapeutics funding

Companies related to Soley Therapeutics (36)

Browse related funding lists (6)